ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Health Technology

Suzuken Co., Ltd.

Business Summary

Suzuken Co., Ltd. engages in the pharmaceutical business. It operates through the following segments: Pharmaceutical Wholesale, Pharmaceutical Manufacturing, Insurance Pharmacy, and Healthcare-related Services. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic reagents, medical equipment, and supplies. The Pharmaceutical Manufacturing segment manufactures and sells pharmaceuticals and diagnostic reagents. The Insurance Pharmacy segment prepares medicines based on prescriptions from medical institutions. The Healthcare-related Services segment includes medical book sales, medical device manufacturing, and drug transportation businesses. The company was founded by Kenzo Suzuki on November 13, 1932 and is headquartered in Nagoya, Japan.

Financial Highlights

Mar 2022 JPYUSD
Revenue2,232.77B19,869.36M
Gross Profit160,994M1,432.67M
Operating income13,778M122.60M
Income before tax22,484M200.08M
Net income14,394M128.09M
EBITDA23,797M211.76M
Diluted EPS163.181.45
Dividends Per Share720.64
Total Assets1,141.71B9,406.52M
Total liabilities723,653M5,962.12M
Total equity417,687M3,441.29M
Operating cash flow9,520M84.71M
Currency in JPYCurrency in USD

Historical Data

 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 2,124.01B 2,132.34B 2,213.53B 2,128.47B 2,232.77B
Gross Profit 187,512M 189,295M 194,124M 157,841M 160,994M
Operating income 19,737M 27,229M 32,572M 9,158M 13,778M
Income before tax 28,766M 45,479M 41,808M 12,557M 22,484M
Net income 18,821M 30,205M 28,213M 7,896M 14,394M
EBITDA 31,800M 38,788M 43,998M 19,466M 23,797M
Diluted EPS 198.21 322.72 310.26 88.51 163.18
Dividends Per Share 64 69 72 72 72
Total Assets 1,173.32B 1,189.23B 1,112.50B 1,114.42B 1,141.71B
Total liabilities 766,896M 787,611M 699,796M 696,508M 723,653M
Total equity 405,752M 400,775M 411,839M 417,048M 417,687M
Operating cash flow 98,066M 41,751M -25,817M 15,602M 9,520M
 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 19,164.21M 19,228.56M 20,358.85M 20,069.11M 19,869.36M
Gross Profit 1,691.85M 1,706.98M 1,785.44M 1,488.25M 1,432.67M
Operating income 178.07M 245.53M 299.57M 86.34M 122.60M
Income before tax 259.54M 410.10M 384.52M 118.39M 200.08M
Net income 169.81M 272.37M 259.48M 74.45M 128.09M
EBITDA 286.91M 349.77M 404.66M 183.54M 211.76M
Diluted EPS 1.78 2.91 2.85 0.83 1.45
Dividends Per Share 0.57 0.62 0.66 0.67 0.64
Total Assets 11,032.68M 10,744.34M 10,305.28M 10,085.25M 9,406.52M
Total liabilities 7,211.05M 7,115.78M 6,482.29M 6,303.24M 5,962.12M
Total equity 3,815.25M 3,620.86M 3,814.91M 3,774.19M 3,441.29M
Operating cash flow 884.81M 376.49M -237.45M 147.10M 84.71M

Valuation Measures

Mar 2022
PER22.24
ROA1.27%
ROE3.44%
Operating margin0.61%
Profit margin0.64%

Key executives

  • President & Representative Director: Shigeru Asano
  • Executive Officer & Compliance Manager: Asako Tomita
  • Manager-Business Administration: Masahiro Hamanaka
  • Director & Senior Managing Executive Officer: Hisashi Tamura
  • Director, Head-Internal Control & Audit: Chie Takahashi

Shareholders

  • Suzuken Co., Ltd. (14.8%)
  • Silchester International Investors LLP (9.2%)
  • Shionogi & Co., Ltd. (3.1%)
  • BESSHO YOSHIKI (2.9%)
  • IZAWA HISAYO (2.3%)
  • Nomura Asset Management Co., Ltd. (2.2%)
  • NAGAI CHIKA (2.2%)
  • BESSHO MASAKI (2.1%)
  • Kopernik Global Investors LLC (2.0%)
  • Suzuken Group Employee Stock Ownership Plan (1.8%)

Contact Details

  • Website:http://www.suzuken.co.jp
  • Address: 8 Higashi Kataha-machi, Higashi-Ku, Nagoya, 461-8701, Japan
  • Phone: +81.52.961.2331

Related Companies

  • S.D. Collabo Co., Ltd.
  • S-Care Mate Co., Ltd.
  • Life Medicom Co., Ltd.
  • Suzuken Restricted Stock Compensation Plan
  • Embrace Co., Ltd.
  • Suzuken Trust
  • Suzuken Medical Information Bank KK
  • Ryomo Iyakuhin KK
  • Nakano Yakuhin KK
  • Medicis KK
  • Suzuken Okinawa Yakuhin Co., Ltd.
  • Chugoku Farmacy KK
  • Astis Co., Ltd.
  • Akiyama Butsuryu Service KK
  • Sanki Wellbe KK
  • Owl Chozai KK
  • Suzuken Logicom Corp.
  • Pfercos Co., Ltd.
  • Suzuken Iwate Co., Ltd.
  • Kenzmedico Co., Ltd.
  • Sanki Corp.
  • Akiyama, Inc.
  • Pfercos KK
  • Jingu Yakuhin KK
  • Omori Yakuhin Co. Ltd.
  • Shoyaku Co., Ltd.
  • Okinawa Yakuhin
  • Sanki Co., Ltd. /Medical/
  • Suzuken Group Employee Stock Ownership Plan
  • Chuo Unyu Co., Ltd.

Competitors

  • Sienna Biopharmaceuticals, Inc.
Last Updated on 4 Oct, 2022

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more